Cancer & Disease Research
Calculator identifies myeloma patients with favorable prognoses
Researchers have developed a calculator tool that identifies patients with more benign forms of two blood cancers: multiple myeloma and primary amyloidosis. Their research, published in the Journal of Clinical Oncology, indicates that the tool could become part of the diagnostic workup of such patients, and help individualize their treatments. Read More
Getting to know the Association of Biomolecular Resource Facilities (ABRF)
The Association of Biomolecular Resource Facilities (ABRF) will hold its Annual Meeting May 7 to May 10 in Boston. ABRF is a membership organization that brings together Core facilities across the U.S. and supports more than 2,400 members at over 400 institutions including organizations in government, academia, research, industry, and commercial settings. Over 50% of its members define their area of professional responsibility as either genomics or core administration. Read More
Gene variant map helps diagnose hereditary diabetes
University of Copenhagen researchers are using high-throughput experiments to explore connections between inherited diseases and a specific gene called GCK. The study, published April 26 in Genome Biology, may help provide better diagnoses of hereditary diabetes and other diseases. Read More
Chemotherapy delivery to human brain marks a first
Northwestern Medicine scientists have used a novel, skull-implantable ultrasound device to allow the delivery of intravenously injected chemotherapy into the brain. The study, published Tuesday in the Lancet Oncology, represents the first human clinical trial to temporarily open the blood-brain barrier for chemotherapy. Read More
Opioid receptor analysis reveals way to treat pain without causing euphoria or hallucinations
The analysis of an opioid receptor has revealed a potential way to treat pain without causing addiction or hallucinations, two key barriers to the safe use of painkillers today. Read More
Medicinal cannabis in study relieves cancer pain, curbs opioid use
A multicenter registry study found that medicinal cannabis safely relieved cancer patients’ pain, while curbing the total number of medications and opioids they took. The research, published Tuesday in BMJ Supportive & Palliative Care, indicates that products with an equal balance of tetrahydrocannabinol (THC) and cannabidiol (CBD) seem to be particularly effective. Read More
Bio-Techne fiscal Q3 sales rise 1% on strength in cell therapy, prostate test products
Bio-Techne on Wednesday reported fiscal third-quarter sales of $294.1 million, up 1% compared to $290.4 million in the prior-year quarter and short of analysts’ average estimate of $296.7 million. Read More
FDA approves first respiratory syncytial virus vaccine
The U.S. Food and Drug Administration (FDA) said Wednesday that it has approved the use of GlaxoSmithKline Biologicals’ Arexvy vaccine for respiratory syncytial virus (RSV). Read More
Dual CRISPR gene-editing therapy eliminates HIV infections in mice
Combining a dual CRISPR gene-editing therapy with antiretroviral drugs can eliminate HIV infections in mice, according to a study published in the Proceedings of the National Academy of Sciences. Read More
FDA issues draft guidance for implementing decentralized clinical trials
The U.S. Food and Drug Administration (FDA) on Tuesday said that it is taking additional steps to support the use of decentralized clinical trials (DCTs) for drugs, biologics, and devices, where some or all the trial-related activities occur at locations other than traditional clinical trial sites. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter